We’re currently experiencing extremely high call volumes. We’re very sorry for any inconvenience this might cause.

If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Faes Farma SA (FAE) EUR0.1

Sell:€3.50 Buy:€3.59 Change: €0.1 (2.90%)
Market closed |  Prices as at close on 31 March 2020 | Switch to live prices |
Change: €0.1 (2.90%)
Market closed |  Prices as at close on 31 March 2020 | Switch to live prices |
Change: €0.1 (2.90%)
Market closed |  Prices as at close on 31 March 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.

Contact details

Edificio 2, 2 Izquierda
+34 (914) 680800

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€982.66 million
Shares in issue:
280.92 million
Madrid Stock Exchange
Madrid General Index

Key personnel

  • Mariano Ucar Angulo
    Executive Chairman of the Board
  • Valentin Ruiz Unamunzaga
    Corporate Chief Financial Officer
  • Helder Cassis
    General Director of Vitoria Laboratories
  • Luis Proenca
    General Director of Vitoria Laboratories
  • Gonzalo Lopez Casanueva
    General Director
  • Francisco Quintanilla Guerra
    General Director
  • German Fernandez-Cano Diaz
    Director of Sales, Executive Director of Nutrition and Animal Health
  • Francisco Perello Font
    Director of Marketing
  • Eduardo Hermo Blanco
    Director of Human Resources
  • Xavier Arnaud
    Director of Corporate Business Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.